{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:49:11Z","timestamp":1780631351344,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Urology, Gifu Graduate School of Medicine"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.bbrc.2016.09.128","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T02:58:32Z","timestamp":1475204312000},"page":"808-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel"],"prefix":"10.1016","volume":"479","author":[{"given":"Sayaka","family":"Sobue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Murate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.09.128_bib1","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","article-title":"Global patterns of cancer incidence and mortality rates and trends","volume":"19","author":"Jemal","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.bbrc.2016.09.128_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0165-6147(92)90048-B","article-title":"Mechanism of action of taxol","volume":"13","author":"Horwitz","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2016.09.128_bib3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1073\/pnas.77.3.1561","article-title":"Taxol stabilizes microtubules in mouse fibroblast cells","volume":"77","author":"Schiff","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.09.128_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2016.09.128_bib5","first-page":"96","article-title":"Taxanes, microtubules and chemoresistant breast cancer","volume":"1785","author":"McGrogan","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2016.09.128_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cyto.2013.06.313","article-title":"CCR1\/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2\/9 and by activating ERK and Rac signaling","volume":"64","author":"Kato","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.bbrc.2016.09.128_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1758834012449685","article-title":"Overcoming docetaxel resistance in prostate cancer: a perspective review","volume":"4","author":"Hwang","year":"2012","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.bbrc.2016.09.128_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbagrm.2014.02.004","article-title":"Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines","volume":"1839","author":"Nishida","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2016.09.128_bib9","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/leu.2009.13","article-title":"GATA-1 and GATA-2 binding to 3' enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines","volume":"23","author":"Furuhata","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2016.09.128_bib10","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/pros.20581","article-title":"The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines","volume":"67","author":"Takeda","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.bbrc.2016.09.128_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-1-4939-3542-0_25","article-title":"Anti-microtubule drugs","volume":"1413","author":"Florian","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2016.09.128_bib12","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3892\/or.2012.2060","article-title":"Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1\/CIP1, in human breast cancer cells","volume":"28","author":"Choi","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2016.09.128_bib13","first-page":"937","article-title":"Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity","volume":"1","author":"Blagosklonny","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2016.09.128_bib14","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/emboj\/cdg115","article-title":"HDAC-6 interacts with and deacetylates tubulin and microtubules in\u00a0vivo","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO. J."},{"key":"10.1016\/j.bbrc.2016.09.128_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ygyno.2010.07.036","article-title":"Suberoylanilide hydroxamic acid partly reverses resistance to paclitaxel in human ovarian cancer cell lines","volume":"119","author":"Angelucci","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbrc.2016.09.128_bib16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1210\/mend-2-8-756","article-title":"Evidence that the 90-kilodalton heat shock protein is associated with tubulin-containing complexes in L cell cytosol and in intact PtK cells","volume":"2","author":"Sanchez","year":"1988","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2016.09.128_bib17","first-page":"875824","article-title":"The role of HDAC6 in cancer","volume":"2011","author":"Aldana-Masangkay","year":"2011","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.bbrc.2016.09.128_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5582\/ddt.2013.v7.6.233","article-title":"HDAC6: physiological function and its selective inhibitors for cancer treatment","volume":"7","author":"Yang","year":"2013","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.bbrc.2016.09.128_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbrc.2008.09.086","article-title":"Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells","volume":"377","author":"Fujita","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2016.09.128_bib20","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1073\/pnas.0503221102","article-title":"Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma","volume":"102","author":"Hideshima","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.09.128_bib21","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa041318","article-title":"Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer","volume":"351","author":"Petrylak","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2016.09.128_bib22","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2016.09.128_bib23","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1158\/1078-0432.CCR-12-3146","article-title":"Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors","volume":"19","author":"Vrignaud","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2016.09.128_bib24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00280-014-2394-z","article-title":"Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer","volume":"73","author":"Mukai","year":"2014","journal-title":"Cancer. Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2016.09.128_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcb.10699","article-title":"Cell cycle checkpoints and their impact on anticancer therapeutic strategies","volume":"91","author":"Eastman","year":"2004","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.bbrc.2016.09.128_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/MCB.01536-07","article-title":"p27kip1 deficiency impairs G2\/M arrest in response to DNA damage, leading to an increase in genetic instability","volume":"28","author":"Payne","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2016.09.128_bib27","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/sj.onc.1203546","article-title":"Differential modulation of paclitaxel-mediated apoptosis by p21Waf1 and p27Kip1","volume":"19","author":"Schmidt","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2016.09.128_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2007.01.003","article-title":"Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy","volume":"10","author":"Maddika","year":"2007","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbrc.2016.09.128_bib29","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1158\/1535-7163.MCT-14-0265","article-title":"Antiproliferative mechanism of action of the novel taxane cabazitaxel as compared with the parent compound docetaxel in MCF7 breast cancer cells","volume":"13","author":"Azarenko","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2016.09.128_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1091\/mbc.e13-07-0387","article-title":"Effects of tubulin acetylation and tubulin acetyltransferase binding on microtubule structure","volume":"25","author":"Howes","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbrc.2016.09.128_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.09.128_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molcel.2007.05.033","article-title":"HDAC6 modulates cell motility by altering the acetylation level of cortactin","volume":"27","author":"Zhang","year":"2007","journal-title":"Mol. Cell"},{"issue":"Pt 21","key":"10.1016\/j.bbrc.2016.09.128_bib33","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1242\/jcs.112.21.3713","article-title":"Decreasing oncoprotein 18\/stathmin levels reduces microtubule catastrophes and increases microtubule polymer in\u00a0vivo","volume":"112","author":"Howell","year":"1999","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.bbrc.2016.09.128_bib34","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1002\/j.1460-2075.1996.tb00914.x","article-title":"Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics","volume":"15","author":"Marklund","year":"1996","journal-title":"EMBO. J."},{"key":"10.1016\/j.bbrc.2016.09.128_bib35","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1007\/s13277-015-3361-y","article-title":"Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer","volume":"36","author":"Sun","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbrc.2016.09.128_bib36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/cas.12417","article-title":"Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma","volume":"105","author":"Watanabe","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2016.09.128_bib37","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1158\/1535-7163.MCT-06-0209","article-title":"Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells","volume":"5","author":"Dowdy","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2016.09.128_bib38","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.biocel.2007.03.001","article-title":"Histone deacetylase inhibitors: signalling towards p21cip1\/waf1","volume":"39","author":"Ocker","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16316023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16316023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T12:26:02Z","timestamp":1657369562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16316023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0006291X16316023"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.128","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}